AstraZeneca Sues To Protect Accolate

Law360, New York (July 1, 2008, 12:00 AM EDT) -- Drug manufacturers AstraZeneca UK Limited and AstraZeneca Pharmaceuticals LP have filed a patent infringement lawsuit seeking to prevent Dr. Reddy's Laboratories Ltd. of India from making a generic version of AstraZeneca's asthma treatment drug Accolate.

AstraZeneca's suit, filed Friday in the U.S. District Court for the District of New Jersey against Dr. Reddy's Laboratories Ltd. and its North American subsidiary, Dr. Reddy's Laboratories Inc., claims the generics maker's application for regulatory approval to make and sell tablets of zafirlukast, the generic name for Accolate, infringes three...
To view the full article, register now.